Autologous T-cell vaccines materials and methods

Details for Australian Patent Application No. 2005202767 (hide)

Owner Baylor College of Medicine Opexa Pharmaceuticals, Inc.

Inventors Zang, Jingwu Zhang

Agent Shelston IP

Pub. Number AU-A-2005202767

Parent 2002339914

Filing date 24 June 2005

Wipo publication date 14 July 2005

International Classifications

A61K 039/00 Medicinal preparations containing antigens or antibodies

Event Publications

14 July 2005 Application Open to Public Inspection

  Published as AU-A-2005202767

14 July 2005 Complete Application Filed

23 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202768-Transgenic Mammals Having Human IG LOCI Including Plural Vh and Vk Regions and Antibodies Produced Therefrom

2005202766-Improved actuator for actuating onboard devices on a sailboat